GS-9190, a novel substituted imidazo-pyridine analogue, is a potent inhibitor of hepatitis C virus replication in vitro and remains active against known drug-resistant mutants — Inge Vliegen (2007) | RDL Network
GS-9190, a novel substituted imidazo-pyridine analogue, is a potent inhibitor of hepatitis C virus replication in vitro and remains active against known drug-resistant mutants
Lotte Coelmont, Jan Paeshuyse, Artur Kaul, Inge Vliegen, De Clercq Erik, Piétro Scalfaro, Brigitte Rosenwirth, R. Crabbé, JM Dumont, Ralf Bartenschlager, Johan Neyts
Inge Vliegen, Jan Paeshuyse, Weidong Zhong, Laura S. Lehman, Sofie Roofthooft, Hélène Dutartre, Barbara Selisko, Bruno Canard, Steven Bondy, David Oare, De Clercq Erik, William A. Lee, Gerhard Pürstinger, Johan Neyts
Lotte Coelmont, Jan Paeshuyse, Suzanne J. F. Kaptein, Inge Vliegen, Ajay Kaul, De Clercq Erik, Brigitte Rosenwirth, Piétro Scalfaro, R. Crabbé, Ralf Bartenschlager
Discussion(0)
No comments yet. Be the first to comment.